透過您的圖書館登入
IP:18.119.253.93

摘要


以具有B型肝炎病毒基因體嵌入其內之人類肝癌細胞株MS-G2,進行34種中藥抗B型肝炎病毒之篩檢。結果顯示陳皮、黄芩、白豆蔻及茵陳等四個單味藥,在200μg/ml時具有抑制B型肝炎病毒表面抗原(HBsAg)之作用。其抑制百分比分別爲37.5、41.3、28.9及21.9%。紅棗具有抑制B型肝炎病毒表面抗原及e抗原之作用,其抑制百分比分別爲35.2及26.1%。其餘29種中藥,在200μg/m1時不具有抑制B型肝炎病毒之作用。

關鍵字

B型肝炎病毒 陳皮 黄芩 白豆蔻 茵陳 紅棗

並列摘要


Using the MS-G2 strain of the human hepatoma cell line that had been integrated with hepatitis-B viral gene, we screened 34 Chinese herbal drugs for their anti-hepatitis-B activity. The result showed that the four simple herbs Citri Leiocarpae Exocarpium, Scutellariae Radix, Amomi Rotundi Fructus and Artemisiae Capillaris Herba possessed anti-hepatitis-B surface antigen activity at 200μg/mL. The inhibitory activities were 37.5, 41.3, 28.9 and 21.9% respectively. At 200 μg/mL, Zizyphi Fructus possessed anti-hepatitis-B surface antigen and e antigen activity, with inhibitory activities of 35.2 and 26.1% respectively. The other 29 Chinese herbal drugs did not possess anti-hepatitis-B activity at 200 μg/mL.

延伸閱讀